概括
患有XI因子缺乏症的患者尽管存在长期出血风险,但仍可能发生肺栓塞. 对这些患者来说,静脉血栓症的预防计划是必不可少的. 对所有手术患者来说,手术前对出血障碍的查至关重要.
科学领域:
- 血液学 血液学 血液学
- 血管医学 血管医学
- 血栓形成的研究研究
背景情况:
- 十一因子缺乏症是一种罕见的遗传性出血障碍.
- 手术后静脉血栓栓塞 (VTE) 是一个重要的临床问题.
- 低剂量肝素通常用于静脉瘤预防.
研究的目的:
- 调查严重XI因子缺乏症患者肺栓塞风险.
- 评估标准静脉血栓塞预防在XI因子缺乏患者的疗效.
主要方法:
- 一个患有严重XI因子缺乏症的患者的病例报告.
- 分析患者的术后病程和并发症.
- 对有关XI因子缺乏和血栓形成的现有文献的综述.
主要成果:
- 该患者的XI因子活性低于1%,在术后发生了肺栓塞.
- 患者经历了长时间的出血,符合XI因子缺乏.
- 缺陷状态不会对静脉血栓栓塞产生保护.
结论:
- 缺乏XI因子并不能防止肺栓塞.
- 在接受手术的XI因子缺乏患者中,应实施静脉血栓预防策略.
- 建议所有接受低剂量肝素手术患者进行部分血栓形成时间的术前查,以检测未被诊断的出血障碍.
相关概念视频
Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pneumothorax-I
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Atelectasis II: Pathophysiology
Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pulmonary Edema II: Pathophysiology
Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...


